Skip to content

Effect of heparin and enoxaparin in patients undergoing primary angioplasty

Comparison of efficacy and safety of Heparin and Enoxaparin versus control group in patients undergoing primary percutaneous intervention: An open labelled randomized clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220809055645N4
Enrollment
171
Registered
2023-05-23
Start date
2023-05-22
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction

Interventions

Intervention 1: Intervention group: The first intervention group includes 57 patients with myocardial infarction who will undergo percutaneous coronary intervention (PCI). These patients will enter th

Sponsors

Rasht University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Myocardial infarction with ST segment elevation

Exclusion criteria

Exclusion criteria: Having coagulopathy Having no consent to participate in the study and follow-up courses Having underlying bleeding disorders, mechanical valve history Presence of other indications for receiving anticoagulants Absolute prohibition of receiving anticoagulants (such as active bleeding at the time of visit, drug sensitivity) GFR lower than 30 liver failure

Design outcomes

Primary

MeasureTime frame
Incidence of stroke. Timepoint: 40 days after primary angioplasty. Method of measurement: By using clinical documents of patients and asking them.;Cardiac death. Timepoint: 40 days after primary angioplasty. Method of measurement: By using clinical documents of patients.;Recurrent myocardial infarction. Timepoint: 40 days after primary angioplasty. Method of measurement: By using clinical documents of patients.

Secondary

MeasureTime frame
Mean ejection fraction of the left ventricle. Timepoint: 40 days after primary angioplasty. Method of measurement: Echocardiography.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Baharvand

Rasht University of Medical Sciences

dr.baharcardio@gmail.com+98 13 3361 8177

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026